Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
The latest update is out from DENTSPLY SIRONA ( (XRAY) ).
On February 5, 2025, Dentsply Sirona’s Board announced the appointment of Michael J. Barber and Daniel T. Scavilla as new directors, expanding the Board from 10 to 11 members. Barber, with a background in product management and innovation at GE, and Scavilla, CEO of Globus Medical, are expected to contribute significantly to Dentsply Sirona’s transformation strategy and strategic growth. Concurrently, Dr. Dorothea Wenzel resigned from the Board due to the increased demands of her new chair nomination. The appointments aim to enhance expertise in healthcare, technology, and finance to support the company’s vision of transforming dentistry.
More about DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, providing comprehensive solutions for dental and oral health care. With a focus on innovation and service, the company aims to enhance patient care and advance safety in dental practices globally. Headquartered in Charlotte, North Carolina, Dentsply Sirona’s products are marketed under a strong portfolio of world-class brands and are traded on Nasdaq under the symbol XRAY.
YTD Price Performance: 2.88%
Average Trading Volume: 3,337,668
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.83B
Learn more about XRAY stock on TipRanks’ Stock Analysis page.
